Email Us
Call Us
AUSTIN, Texas – February 17, 2024 – Altogen Labs, a leading contract research organization specializing in preclinical research services for pharmaceutical, biotechnology, and academic institutions worldwide, joined Medical Technology Consortium.
Altogen Labs’ focus areas as oncology, gene silencing, xenograft models, and advanced biotechnology services including stable cell line development, RNA interference, and in vivo imaging. Company offers extensive experience in cancer research, xenograft model development, and gene modulation, and aim of accelerating drug development and personalized medicine through oncology preclinical research and GLP-compliant solutions.
Altogen Labs has operated from its GLP-compliant, IACUC-regulated Austin, Texas facility since 2009. Its validated model collection, 98 CDX models, 47 PDX models, and 14 syngeneic murine models, together with patient-derived cell cultures, patient-derived organoids, and new approach methodologies — supports efficacy testing across every major solid tumor and hematologic malignancy. Immuno-oncology programs are served by humanized and immunodeficient rodent models engrafted with PBMC, CD34+ hematopoietic stem cells, and iPSC.
Safety services include acute, sub-chronic, and chronic toxicology, in vivo LD50 studies, and OECD-guideline testing supporting IND applications. Sponsors receive complete study documentation and retain 100% of resulting intellectual property.
About Altogen Labs Altogen Labs is a professional, experienced, and highly reputable GLP-compliant contract research organization providing preclinical research services and biology CRO services worldwide. The company maintains a large collection of in-house validated xenograft models (CDX, PDX, syngeneic, organoids, NAMs) and extensive experience in efficacy xenograft studies and safety toxicology studies for IND applications and regulatory submissions.
Contact Information: Altogen Labs | 11200 Menchaca Rd, Bldg 2, Suite 203 | Austin, TX 78748 USA Tel: 512-433-6177 | Email: info@altogenlabs.com | Web: altogenlabs.com